Sleepiness, DaytimeHighWay2HealthNCT05096130
Lifestyle Medicine Strategies for Combating Sleepiness and Fatigue in Professional Drivers
A study testing Lifestyle Medicine Strategies in people with Sleepiness, Daytime and Fatigue, run by University of Thessaly at 1 site in Greece.
Trial summary
Sleep has a number of health benefits, including memory and learning, vitality and energy as well as high quality of life levels. Lack of sleep impairs judgment, impacts longevity and safety, and increases the risk of a number of diseases including obesity, hypertension, heart disease, diabetes, mood disorders, and… Read more about this study
- Who is it for?
- Ages 25 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Sleepiness, Daytime, Fatigue, Sleep Disorders, Circadian Rhythm
- What is being tested?
- Lifestyle Medicine Strategies
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 0 participants
- Where
- 1 siteGreece
- Study dates
- 1 Sep 2021to 31 Jan 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- both sexes,
- age between 25 and 60 yrs old
- valid 5th category driving license for large trucks and coaches
- minimum of 3 years of continuous and verifiable documented work experience as a professional driver in the past 5 years
- diagnosed with moderate daily sleepiness as this is documented by a value >9 in Epworth Sleepiness Scale (SSC)
Who cannot join
- drivers with a driving license that expires within a year of the recruitment date,
- disabilities that prevent them from walking independently or exercising,
- verified mental illnesses,
- alcoholism or drug abuses,
- or conditions that could affect the outcome of the study
Trial locations and contacts
1 site in 1 country.
Greece1 site
Lifestlye Medicine Laboratory, TEFAA, University of Thessaly
Trikala, Thessaly, 42100
About this study
Official title: The Effect of Lifestyle Modifications on Aspects Related to Fatigue, Quality of Life, Health, and Sleepiness in Professional Drivers
Sleep has a number of health benefits, including memory and learning, vitality and energy as well as high quality of life levels. Lack of sleep impairs judgment, impacts longevity and safety, and increases the risk of a number of diseases including obesity, hypertension, heart disease, diabetes, mood disorders, and impaired immune function. In addition lack of sleep or disturbance of normal sleep cycle could have a major impact on people's lives and working performance such as driving. Daily sleepiness is a problem concerning professions with a non-fixed schedule. Specifically, professional long-haul drivers confront sleepiness problems and in combination with fatigue, they are prone to driving accidents and other incidents. Sleep quality and quantity are closed related to fatigue which is one of the most common reasons for driving and working accidents. In recent years, car accidents involving professional drives have increased significantly. The main reasons for those accidents were fatigue and sleepiness due to long hours of driving or difficult working conditions according to the recent European report (Driver Fatigue in European Road Transport - etf-europe.org).
Lifestyle Medicine addresses health risk factors in primary, secondary, and tertiary prevention of developing disease rather than on acute care and reacting to illness, injury, and disease. Lifestyle Medicine strategies targeting modifiable risk factors, such as diet, sleep, stress, and physical activity. By applying those regimes the investigators could improve physical and mental health levels that can affect the quality of sleep, reducing daily sleepiness and fatigue, in professional drivers operating coaches and trucks. Any intervention that could improve alertness and reduce fatigue and sleepiness in those people, will automatically improve safety, reduce driving accidents and save lives and resources.
Read the detailed description
Methodology Participants: Professional divers with valid 5th category driving license will be the target group of this RCT. All participants will sign an informed consent form in order to participate in the study. Participants will undergo a complete health history and will have the approval of their attending physician. The study has been approved by the local IRB Internal Ethics Committee.
Study Design: This is a randomized clinical trial involving healthy human volunteers. Participants will be assessed before and after a 6-month lifestyle intervention. The current project consists of 9 interconnected Steps:
Step 1: Participants will sign the consent form and complete the PARQ health questionnaire for assessing the readiness to exercise participation followed by the Epworth Sleepiness Scale (SSC) for assessing daily sleepiness.
Step 2: Participants that fulfill the inclusion criteria will be scheduled for a full night Polysomnography test at the sleep unit of the Center of Research and Evaluation of Human Performance (CREHP) laboratory.
Step 3: After completing the polysomnography test, participants will complete a 2h OGTT test for assessing insulin resistance and glucose tolerance. During those two hours, the participants will complete a series of questionnaires assessing aspects related to demographics, quality of life, health, and sleep quality.
Step 4: After the completion of Step 3, participants will go through a body composition analysis using the DEXA method followed by a bioimpedance analysis for assessing total body water levels.
Step 5: After the completion of Step 4, participants will participate in a battery of tests assessing fitness levels and functional capacity. Physical activity levels will be recorded using a mobile application for the duration of a week.
Step 6: After the completion of Step 5, participants will be scheduled after 2 days for a lab Multiple Sleep Latency Test (MSLT) for the assessment of their levels of daily sleepiness.
Step 7: After the completion of Step 6, participants will follow a series of interviews with certified experts. More specifically,
- a registered dietitian will assess nutritional habits and prescribe a corrective diet in order to improve the participants' nutritional profile.
- a registered psychologist will assess mental health and stress levels and suggest corrective approaches for improving participants' stress levels and mental capacity.
- a registered exercise physiologist will assess fitness levels and prescribe an appropriate exercise training program for improving cardiovascular fitness and functional capacity.
- a registered sleep coach will assess sleep quality and hygiene and suggest ways for improving sleep quality and restfulness.
Step 8: After completion of Step 7 participants will be given a 24h Blood Pressure (BP) Holter for assessing the circadian variation of BP and a Heart Rate Variability (HRV) monitor for assessing HRV during a normal working day (including driving).
Step 9: After the completion of all steps, participants will be randomly assigned to one of the two groups based on demographic and sleep parameters: the control group (CON) and the experimental group (EXP).
Intervention: The intervention of the current project includes 6 months of lifestyle modification counseling based on the guidelines and principles of the European Lifestyle Medicine Organization (eulm.org). More specifically, counseling will target areas such as nutrition, exercise, stress, and sleep. A certified specialist will interview and assess all participants and prescribe the appropriate corrective regimes for improving participants' lifestyles and reducing cardiovascular risk factors. More particularly, for nutritional counseling a customized diet will be provided and change every two weeks, for exercise counseling, a customized supervised exercised training will be provided and change every two weeks, for psychological counseling, a customized psychological approach will be provided and reassessed every two weeks and for sleep counseling, a customized sleep hygiene program will be provided and reevaluated every month.
Randomization: Randomization will take place using a randomization computer software. Randomization will consider parameters such as gender, age, BMI, and sleepiness score.
Measurements:
Demographic Characteristics: Demographic characteristics include age, gender, race/ethnicity, education, socioeconomic status, health, disability status, and work-related information.
Questionnaires: Various validated questionnaires will be used for the assessment of aspects related to the quality of life and health using the interview method.
General Health: The PARQ questionnaire will be used for the assessment of the level of readiness to participate in an exercise training program. The General Health Questionnaire 30 (GHQ30) will be used for the assessment of the general health status of the participants. Charlson Comorbidity index will be used for the calculation of the comorbidity index.
Sleepiness and Quality of Sleep: The Epworth Sleepiness Scale (ESS) will be used for the assessment of the level of sleepiness. The Pittsburgh Sleep Quality Index (PSQI) will be used for the assessment of sleep quality and sleep abnormalities. Furthermore, the Karolinska Sleepiness Scale (KSS) will be used for the assessment of alertness and vitality. Finally, the Daily Sleep Diary will be used for the assessment of the level of sleep quality of the participants.
Fatigue levels: The Fatigue Severity Scale (FSS) will be used for the assessment of the level of general fatigue.
The quality of life: The SF36QoL questionnaire (SF-36) will be used for the assessment of the levels of quality of life.
Depressive symptoms: The Beck Depression Inventory (BDI) questionnaire will be used for the assessment of depressive symptoms and signs.
Stress: The Perceived Stress Scale (PSS) and the Work Stress Questionnaire (WSQ) will be used for the assessment of stress levels.
Physical Activity: The International Physical Activity Questionnaire (IPAQ) will be used for the assessment of physical activity levels.
Driving Skills and Habits: The Driving Habits Questionnaire (DHQ) will be used for the assessment of driving habits.
Nutrition: The General Nutrition Knowledge Questionnaire (GNKQ) will be used for the assessment of nutritional knowledge and habits.
Biochemical Analysis: Blood samples will be collected after overnight fasting for measurement of lipids, hormones, and general hematology analysis. Glucose disposal and indices of insulin resistance will be assessed by an Oral Glucose Tolerance Test (Blood samples will be collected 0, 30, 60, 90, and 120 minutes following ingestion of 75gr of glucose). The insulin resistance index will be calculated by the OGIS and HOMA-IR equations.
Body Composition: Body composition will be assessed using anthropometric measurements including BMI, WHR as well as DEXA scans for the assessment of total and regional fat and lean body mass (Lunar model DPX Madison, WI). Intracellular and extracellular as well as total body water levels will be measured by bioimpedance using a portable BIA system, (Tanita BC 543).
Blood Pressure: The circadian blood pressure variation will be assessed using a 24h BP Holter (GIMA 24HABPM).
Heart Rate Variability: Heart Rate Variability will be assessed using a portable ECG designed to measure all HRV indices (OMRON HCG-801).
Sleep Quality Assessment: Quality and quantity of sleep will be assessed by an overnight Polysomnographic study (PSG). Levels of daily sleepiness will be assessed using the Multiple Sleep Latency Test (MSLT). MSLT is a full-day test that consists of five scheduled naps separated by two-hour breaks.
Fitness Assessment Physical Activity: A mobile phone-based steps tracking application will be used for the assessment of the weekly physical activity levels.
Aerobic Capacity: The six-minute walk test (6MWT) will be used for the assessment of Aerobic capacity and Endurance.
Strength: 1RM will be used for the assessment for the evaluation of maximum muscle strength. Also, the sit to stand-60sec (STS60) test will be used for the assessment for testing leg strength and endurance. Finally, a 5x sit-to-stand test (STS5) will be used for the assessment of functional lower extremity strength, transitional movements, balance, and fall risk.
Flexibility: The Sit and Reach test (S\&R) will be used for the assessment of flexibility of the lower back and hamstring muscles.
Handgrip: The handgrip test will be used for the assessment of the maximum isometric strength of the hand and for arm muscles (Marsden MG-4800 Hand Dynamometer).
Statistics SPSS statistical software (SPSS 21, Illinois USA) will be used for statistical analysis.
The pre and post within Control (Con) and Exercise (Ex) groups will be examined by using paired t-test. Correlations between (Con) group and (Ex) group parameters will be examined by using Spearman correlation. Also, will be examined Δ change values by using an unpaired t-test.
Power Analysis:
Power analysis was performed using the open-source software G*Power (3.1.9.2) and was used to calculate the minimum number of participants required to achieve reasonable power (>85%). A priori compute required sample size analysis revealed that in one of the main parameters related to the aims of the study (ESS score), the study needs a total sample size of 42 participants (for both groups) in order to have enough power to detect statistically significant differences between the pre and post-intervention comparisons (within groups ESS: Effect size dz=0.4783, total sample size=42, t=2.019, Power (1-β err prob)=0.88289). Given an estimation of a reasonable dropout rate of 20%, it is estimated that a number of 25 participants per group is needed in order to have significant power to achieve meaningful results.
- Being tested
- Lifestyle Medicine Strategies
- Keywords
- driving, lifestyle medicine, Quality of life, Physical Activity, Diet, stress, sleep coaching, road accidents
- Medical subject headings
- Disorders of Excessive Somnolence, Fatigue, Sleep Disorders, Circadian Rhythm, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Lifestyle Medicine StrategiesBehavioural
LM addresses health risk factors in primary, secondary, and tertiary prevention of developing disease rather than limiting resources and medical expenditures on acute care and reacting to illness, injury, and disease.
The intervention will target the four pillars of the LM approach including physical activity, diet, stress, and sleep. Certified in LM strategies professionals will consult participants from the LM group in a biweekly base in order to improve their lifestyle habits.
| Study group | Role | What they receive |
|---|---|---|
| Control Group - No intervention | No intervention | The control group will not participate in any intervention for the duration of the study. In addition, the participants will be instructed to follow their usual daily schedule for 6 months. Changes in health, medication, or habits will be discussed by the investigators' team and reassess the continuation or the termination of the investigated participant. |
| Lifestyle Medicine Strategies Groupo | Experimental | The LSM (LifeStyle Medicine) group, will receive a 6-month lifestyle change intervention targeting the correction of diet, improving physical activity and exercise levels, reducing stress levels, and improving sleep hygiene by LSM registered professionals. Receives: Behavioral: Lifestyle Medicine Strategies |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in Daily Sleepiness
The levels of daily sleepiness will be assessed by a Multiple Sleep Latency Test (MSLT). This is the gold standard approach for assessing daily sleepiness.
Measured: Assessed at 0-month (pre) and at 6-month (post)
Changes in Levels fo Fatigue
The levels of fatigue will be assessed by the FSS test
Measured: Assessed at 0-month (pre) and at 6-month (post)
Changes in Quality of Sleep
Quality of sleep will be assessed by a full night polysomnography study
Measured: Assessed at 0-month (pre) and at 6-month (post)
Secondary outcomes (4)
Changes in Body composition
The changes in body composition will be measured by the DEXA method
Measured: Assessed at 0-month (pre) and at 6-month (post)
Changes in Exercise Capacity
Exercise capacity will be assessed by 6 min walk test
Measured: Assessed at 0-month (pre) and at 6-month (post)
Changes in Stress levels Work Stress Questionnaire
Stress levels will be assessed by validated questionnaires.
Measured: Assessed at 0-month (pre) and at 6-month (post)
Changes in Quality of Life levels
Quality of life will be assessed by SF36 QoL questionnaire.
Measured: Assessed at 0-month (pre) and at 6-month (post)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Oct 2021
- Study start1 Sep 2021
- Primary completion1 Jan 2023
- Study completion31 Jan 2023
Why it stopped: Recruitment difficulties
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Sleepiness, DaytimeStudies of the same condition, open and under way.
- More trials run by University of ThessalyThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This is a randomized controlled trial. The study is composed of two groups. Group 1 is the control group and Group 2 is the experimental one. The trial period will last for 6 months for both groups. Intervention includes lifestyle changes targeting physical activity, diet, stress and sleep quality. The design is parallel.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 0 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Thessaly
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Giorgos K. Sakkas, University of Thessaly
- Investigators
- Giorgos K Sakkas, PhD, Principal investigator, University of ThessalyEfthmios Dardiotis, MD, PhD, Study chair, University of Thessaly
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05096130
- Sponsor's protocol ID
- 1818/09/06/2021
- Acronym
- HighWay2Health
- Status last verified
- Jun 2023
- First submitted
- 30 Sep 2021
- Last updated
- 5 Jun 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Jun 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Lifestyle Modifications on Aspects Related to Fatigue, Quality of Life, Health, and Sleepiness in Professional Drivers
- ClinicalTrials.gov ID
- NCT05096130
- Acronym / sponsor ID
- HighWay2Health / 1818/09/06/2021
- Keywords
- driving, lifestyle medicine, Quality of life, Physical Activity, Diet, stress, sleep coaching, road accidents
- Study type
- Interventional
- Recruitment status
- WithdrawnReason stopped: Recruitment difficulties
- Enrolment
- 0 participants (actual)
- Lead sponsor
- University of ThessalyUniversity, hospital or other
- Study start
- 1 Sep 2021 (actual)
- Primary completion
- 1 Jan 2023 (actual)
- Study completion
- 31 Jan 2023 (actual)
- First posted
- 27 Oct 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Sleep has a number of health benefits, including memory and learning, vitality and energy as well as high quality of life levels. Lack of sleep impairs judgment, impacts longevity and safety, and increases the risk of a number of diseases including obesity, hypertension, heart disease, diabetes, mood disorders, and impaired immune function. In addition lack of sleep or disturbance of normal sleep cycle could have a major impact on people's lives and working performance such as driving. Daily sleepiness is a problem concerning professions with a non-fixed schedule. Specifically, professional long-haul drivers confront sleepiness problems and in combination with fatigue, they are prone to driving accidents and other incidents. Sleep quality and quantity are closed related to fatigue which is one of the most common reasons for driving and working accidents. In recent years, car accidents involving professional drives have increased significantly. The main reasons for those accidents were fatigue and sleepiness due to long hours of driving or difficult working conditions according to the recent European report (Driver Fatigue in European Road Transport - etf-europe.org).
Lifestyle Medicine addresses health risk factors in primary, secondary, and tertiary prevention of developing disease rather than on acute care and reacting to illness, injury, and disease. Lifestyle Medicine strategies targeting modifiable risk factors, such as diet, sleep, stress, and physical activity. By applying those regimes the investigators could improve physical and mental health levels that can affect the quality of sleep, reducing daily sleepiness and fatigue, in professional drivers operating coaches and trucks. Any intervention that could improve alertness and reduce fatigue and sleepiness in those people, will automatically improve safety, reduce driving accidents and save lives and resources.
Detailed description
Methodology Participants: Professional divers with valid 5th category driving license will be the target group of this RCT. All participants will sign an informed consent form in order to participate in the study. Participants will undergo a complete health history and will have the approval of their attending physician. The study has been approved by the local IRB Internal Ethics Committee.
Study Design: This is a randomized clinical trial involving healthy human volunteers. Participants will be assessed before and after a 6-month lifestyle intervention. The current project consists of 9 interconnected Steps:
Step 1: Participants will sign the consent form and complete the PARQ health questionnaire for assessing the readiness to exercise participation followed by the Epworth Sleepiness Scale (SSC) for assessing daily sleepiness.
Step 2: Participants that fulfill the inclusion criteria will be scheduled for a full night Polysomnography test at the sleep unit of the Center of Research and Evaluation of Human Performance (CREHP) laboratory.
Step 3: After completing the polysomnography test, participants will complete a 2h OGTT test for assessing insulin resistance and glucose tolerance. During those two hours, the participants will complete a series of questionnaires assessing aspects related to demographics, quality of life, health, and sleep quality.
Step 4: After the completion of Step 3, participants will go through a body composition analysis using the DEXA method followed by a bioimpedance analysis for assessing total body water levels.
Step 5: After the completion of Step 4, participants will participate in a battery of tests assessing fitness levels and functional capacity. Physical activity levels will be recorded using a mobile application for the duration of a week.
Step 6: After the completion of Step 5, participants will be scheduled after 2 days for a lab Multiple Sleep Latency Test (MSLT) for the assessment of their levels of daily sleepiness.
Step 7: After the completion of Step 6, participants will follow a series of interviews with certified experts. More specifically,
- a registered dietitian will assess nutritional habits and prescribe a corrective diet in order to improve the participants' nutritional profile.
- a registered psychologist will assess mental health and stress levels and suggest corrective approaches for improving participants' stress levels and mental capacity.
- a registered exercise physiologist will assess fitness levels and prescribe an appropriate exercise training program for improving cardiovascular fitness and functional capacity.
- a registered sleep coach will assess sleep quality and hygiene and suggest ways for improving sleep quality and restfulness.
Step 8: After completion of Step 7 participants will be given a 24h Blood Pressure (BP) Holter for assessing the circadian variation of BP and a Heart Rate Variability (HRV) monitor for assessing HRV during a normal working day (including driving).
Step 9: After the completion of all steps, participants will be randomly assigned to one of the two groups based on demographic and sleep parameters: the control group (CON) and the experimental group (EXP).
Intervention: The intervention of the current project includes 6 months of lifestyle modification counseling based on the guidelines and principles of the European Lifestyle Medicine Organization (eulm.org). More specifically, counseling will target areas such as nutrition, exercise, stress, and sleep. A certified specialist will interview and assess all participants and prescribe the appropriate corrective regimes for improving participants' lifestyles and reducing cardiovascular risk factors. More particularly, for nutritional counseling a customized diet will be provided and change every two weeks, for exercise counseling, a customized supervised exercised training will be provided and change every two weeks, for psychological counseling, a customized psychological approach will be provided and reassessed every two weeks and for sleep counseling, a customized sleep hygiene program will be provided and reevaluated every month.
Randomization: Randomization will take place using a randomization computer software. Randomization will consider parameters such as gender, age, BMI, and sleepiness score.
Measurements:
Demographic Characteristics: Demographic characteristics include age, gender, race/ethnicity, education, socioeconomic status, health, disability status, and work-related information.
Questionnaires: Various validated questionnaires will be used for the assessment of aspects related to the quality of life and health using the interview method.
General Health: The PARQ questionnaire will be used for the assessment of the level of readiness to participate in an exercise training program. The General Health Questionnaire 30 (GHQ30) will be used for the assessment of the general health status of the participants. Charlson Comorbidity index will be used for the calculation of the comorbidity index.
Sleepiness and Quality of Sleep: The Epworth Sleepiness Scale (ESS) will be used for the assessment of the level of sleepiness. The Pittsburgh Sleep Quality Index (PSQI) will be used for the assessment of sleep quality and sleep abnormalities. Furthermore, the Karolinska Sleepiness Scale (KSS) will be used for the assessment of alertness and vitality. Finally, the Daily Sleep Diary will be used for the assessment of the level of sleep quality of the participants.
Fatigue levels: The Fatigue Severity Scale (FSS) will be used for the assessment of the level of general fatigue.
The quality of life: The SF36QoL questionnaire (SF-36) will be used for the assessment of the levels of quality of life.
Depressive symptoms: The Beck Depression Inventory (BDI) questionnaire will be used for the assessment of depressive symptoms and signs.
Stress: The Perceived Stress Scale (PSS) and the Work Stress Questionnaire (WSQ) will be used for the assessment of stress levels.
Physical Activity: The International Physical Activity Questionnaire (IPAQ) will be used for the assessment of physical activity levels.
Driving Skills and Habits: The Driving Habits Questionnaire (DHQ) will be used for the assessment of driving habits.
Nutrition: The General Nutrition Knowledge Questionnaire (GNKQ) will be used for the assessment of nutritional knowledge and habits.
Biochemical Analysis: Blood samples will be collected after overnight fasting for measurement of lipids, hormones, and general hematology analysis. Glucose disposal and indices of insulin resistance will be assessed by an Oral Glucose Tolerance Test (Blood samples will be collected 0, 30, 60, 90, and 120 minutes following ingestion of 75gr of glucose). The insulin resistance index will be calculated by the OGIS and HOMA-IR equations.
Body Composition: Body composition will be assessed using anthropometric measurements including BMI, WHR as well as DEXA scans for the assessment of total and regional fat and lean body mass (Lunar model DPX Madison, WI). Intracellular and extracellular as well as total body water levels will be measured by bioimpedance using a portable BIA system, (Tanita BC 543).
Blood Pressure: The circadian blood pressure variation will be assessed using a 24h BP Holter (GIMA 24HABPM).
Heart Rate Variability: Heart Rate Variability will be assessed using a portable ECG designed to measure all HRV indices (OMRON HCG-801).
Sleep Quality Assessment: Quality and quantity of sleep will be assessed by an overnight Polysomnographic study (PSG). Levels of daily sleepiness will be assessed using the Multiple Sleep Latency Test (MSLT). MSLT is a full-day test that consists of five scheduled naps separated by two-hour breaks.
Fitness Assessment Physical Activity: A mobile phone-based steps tracking application will be used for the assessment of the weekly physical activity levels.
Aerobic Capacity: The six-minute walk test (6MWT) will be used for the assessment of Aerobic capacity and Endurance.
Strength: 1RM will be used for the assessment for the evaluation of maximum muscle strength. Also, the sit to stand-60sec (STS60) test will be used for the assessment for testing leg strength and endurance. Finally, a 5x sit-to-stand test (STS5) will be used for the assessment of functional lower extremity strength, transitional movements, balance, and fall risk.
Flexibility: The Sit and Reach test (S\&R) will be used for the assessment of flexibility of the lower back and hamstring muscles.
Handgrip: The handgrip test will be used for the assessment of the maximum isometric strength of the hand and for arm muscles (Marsden MG-4800 Hand Dynamometer).
Statistics SPSS statistical software (SPSS 21, Illinois USA) will be used for statistical analysis.
The pre and post within Control (Con) and Exercise (Ex) groups will be examined by using paired t-test. Correlations between (Con) group and (Ex) group parameters will be examined by using Spearman correlation. Also, will be examined Δ change values by using an unpaired t-test.
Power Analysis:
Power analysis was performed using the open-source software G*Power (3.1.9.2) and was used to calculate the minimum number of participants required to achieve reasonable power (>85%). A priori compute required sample size analysis revealed that in one of the main parameters related to the aims of the study (ESS score), the study needs a total sample size of 42 participants (for both groups) in order to have enough power to detect statistically significant differences between the pre and post-intervention comparisons (within groups ESS: Effect size dz=0.4783, total sample size=42, t=2.019, Power (1-β err prob)=0.88289). Given an estimation of a reasonable dropout rate of 20%, it is estimated that a number of 25 participants per group is needed in order to have significant power to achieve meaningful results.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- This is a randomized controlled trial. The study is composed of two groups. Group 1 is the control group and Group 2 is the experimental one. The trial period will last for 6 months for both groups. Intervention includes lifestyle changes targeting physical activity, diet, stress and sleep quality. The design is parallel.
| Arm | Type | Receives |
|---|---|---|
| Control Group - No intervention | No intervention | –The control group will not participate in any intervention for the duration of the study. In addition, the participants will be instructed to follow their usual daily schedule for 6 months. Changes in health, medication, or habits will be discussed by the investigators' team and reassess the continuation or the termination of the investigated participant. |
| Lifestyle Medicine Strategies Groupo | Experimental | Behavioral: Lifestyle Medicine StrategiesThe LSM (LifeStyle Medicine) group, will receive a 6-month lifestyle change intervention targeting the correction of diet, improving physical activity and exercise levels, reducing stress levels, and improving sleep hygiene by LSM registered professionals. |
Who may qualify
- Ages
- 25 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- both sexes,
- age between 25 and 60 yrs old
- valid 5th category driving license for large trucks and coaches
- minimum of 3 years of continuous and verifiable documented work experience as a professional driver in the past 5 years
- diagnosed with moderate daily sleepiness as this is documented by a value >9 in Epworth Sleepiness Scale (SSC)
Key exclusion criteria (5 listed)
- drivers with a driving license that expires within a year of the recruitment date,
- disabilities that prevent them from walking independently or exercising,
- verified mental illnesses,
- alcoholism or drug abuses,
- or conditions that could affect the outcome of the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Lifestyle Medicine StrategiesLM addresses health risk factors in primary, secondary, and tertiary prevention of developing disease rather than limiting resources and medical expenditures on acute care and reacting to illness, injury, and disease. The intervention will target the four pillars of the LM approach including physical activity, diet, stress, and sleep. Certified in LM strategies professionals will consult participants from the LM group in a biweekly base in order to improve their lifestyle habits. | Behavioural | Lifestyle Medicine Strategies Groupo |
Primary outcome
Changes in Daily Sleepiness
Time frame: Assessed at 0-month (pre) and at 6-month (post)
The levels of daily sleepiness will be assessed by a Multiple Sleep Latency Test (MSLT). This is the gold standard approach for assessing daily sleepiness.
Changes in Levels fo Fatigue
Time frame: Assessed at 0-month (pre) and at 6-month (post)
The levels of fatigue will be assessed by the FSS test
Changes in Quality of Sleep
Time frame: Assessed at 0-month (pre) and at 6-month (post)
Quality of sleep will be assessed by a full night polysomnography study
4 secondary outcomes
Changes in Body composition
Time frame: Assessed at 0-month (pre) and at 6-month (post)
Changes in Exercise Capacity
Time frame: Assessed at 0-month (pre) and at 6-month (post)
Changes in Stress levels Work Stress Questionnaire
Time frame: Assessed at 0-month (pre) and at 6-month (post)
Changes in Quality of Life levels
Time frame: Assessed at 0-month (pre) and at 6-month (post)
Results and safety
The study was withdrawn before enrolling participants, so there are no results.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jun 2023.
- Individual participant dataSharing planned: No
Related trials for Sleepiness, Daytime
RecruitingPhase 3
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)
Apnea, Sleep Disorders
RecruitingPhase 2/3
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
Narcolepsy Type 1, Narcolepsy Type 2
RecruitingPhase 2
A Study to Evaluate the Safety and Efficacy of ALKS 7290 as an Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder
Major Depressive Disorder (MDD)
RecruitingPhase 3
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms
RecruitingPhase 2/3
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Giorgos K Sakkas, PhD principal investigator
University of Thessaly
Efthmios Dardiotis, MD, PhD study chair
University of Thessaly
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Lifestyle Medicine Strategies in people with Sleepiness, Daytime and Fatigue, run by University of Thessaly at 1 site in Greece.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: withdrawn, as of the sponsor's last update on 5 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was withdrawn before enrolling participants, so there are no results.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in Daily Sleepiness (time frame: Assessed at 0-month (pre) and at 6-month (post)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2023.